Isabelle J. Dionne

Sarcopenic/Obesity and Physical Capacity in Older Men and Women: Data From the Nutrition as a Determinant of Successful Aging (NuAge)—the Quebec Longitudinal Study

Sarcopenia and obesity have been independently associated with physical capacity impairments. However, few studies have investigated the impact of sarcopenic/obesity on physical capacity in older individuals using objective measures of physical capacity and body composition. This study included 904 older individuals aged between 68 and 82 years old. Body composition (fat mass (FM) and lean body mass (LBM) by dual‐energy X‐ray absorptiometry (DXA)), physical capacity (timed up and go, chair stands, walking speed at normal and fastest pace, and one leg stand), sum of reported chronic conditions and physical activity level were measured. A global physical capacity score was then calculated giving a maximal score of 20. Finally, four groups were created within genders based on sarcopenia and obesity ((i) nonsarcopenic/nonobese; (ii) sarcopenic/nonobese; (iii) nonsarcopenic/obese; (iv) sarcopenic/obese). The four groups were significantly different for the sit‐to‐stand test and the one leg stand test (P < 0.05) and only for the one leg stand test in women (P < 0.05). In both genders results for the global physical capacity score revealed that both obese groups (sarcopenic and nonsarcopenic) were similar (P = 0.14 in men and P = 0.19 in women) and had a lower global physical capacity score compared to nonsarcopenic/nonobese individuals (P < 0.05). In addition, sarcopenic women displayed a higher score than both obese nonsarcopenic and obese sarcopenic groups (P < 0.01). Sarcopenic/obese men and women do not display lower physical capacity compared to nonsarcopenic/obese individuals in this cohort of well‐functioning older men and women. Obesity per se appears to contribute more to lower physical capacity than sarcopenia.

Effect of sarcopenia on cardiovascular disease risk factors in obese postmenopausal women.

Objective: To compare sarcopenic‐obese and obese postmenopausal women for risk factors predisposing to cardiovascular disease (CVD) and determine whether there may be a relationship between muscle mass and metabolic risk in obese postmenopausal women.

The function of DNA polymerase alpha at telomeric G tails is important for telomere homeostasis.

ABSTRACT Telomere length control is influenced by several factors, including telomerase, the components of telomeric chromatin structure, and the conventional replication machinery. Although known components of the replication machinery can influence telomere length equilibrium, little is known about why mutations in certain replication proteins cause dramatic telomere lengthening. To investigate the cause of telomere elongation in cdc17/pol1 (DNA polymerase α) mutants, we examined telomeric chromatin, as measured by its ability to repress transcription on telomere-proximal genes, and telomeric DNA end structures in pol1-17 mutants. pol1-17 mutants with elongated telomeres show a dramatic loss of the repression of telomere-proximal genes, or telomeric silencing. In addition,cdc17/pol1 mutants grown under telomere-elongating conditions exhibit significant increases in single-stranded character in telomeric DNA but not at internal sequences. The single strandedness is manifested as a terminal extension of the G-rich strand (G tails) that can occur independently of telomerase, suggesting thatcdc17/pol1 mutants exhibit defects in telomeric lagging-strand synthesis. Interestingly, the loss of telomeric silencing and the increase in the sizes of the G tails at the telomeres temporally coincide and occur before any detectable telomere lengthening is observed. Moreover, the G tails observed incdc17/pol1 mutants incubated at the semipermissive temperature appear only when the cells pass through S phase and are processed by the time cells reach G1. These results suggest that lagging-strand synthesis is coordinated with telomerase-mediated telomere maintenance to ensure proper telomere length control.

Impact of resistance training with or without caloric restriction on physical capacity in obese older women.

Objective: To investigate the specific impact of resistance training (RT) with or without caloric restriction (CR) on physical capacity in obese older women. Design: Forty-eight postmenopausal obese women, physically independent and between the ages of 55 and 75 years were recruited. The women were randomly assigned to one of four groups (1: RT [n = 12], 2: CR [n = 12], 3: CR + RT [n = 12], or 4: control group [C; n = 12]) for 3 months. CR and CR + RT groups participated in a weekly group session on nutrition, and RT and CR + RT groups took part in a resistance training program. Physical capacity was measured with 11 different performance tests. A global physical capacity score (range, 0-44) was then computed using quartiles of each test. Body composition was measured by dual-energy x-ray absorptiometry. Results: Body weight, total fat mass, percentage of fat mass, and body mass index (kg/m2) significantly decreased in the CR and CR + RT groups (P < 0.01), whereas only the CR group showed a significant decrease in lean body mass (P < 0.05) after the 3-month program. The global physical capacity score significantly improved in the RT group (10.0 ± 8.8%; P < 0.01), compared with the C group after 3 months. Conclusion: Overall, the 3-month RT program alone had a greater effect on physical capacity than CR or CR + RT. Thus, a 3-month RT could help prevent long-term decreases in physical capacity in obese older women.

Effect of 6 months of exercise and isoflavone supplementation on clinical cardiovascular risk factors in obese postmenopausal women: a randomized, double-blind study.

Objective:To investigate whether 6 months of exercise combined with isoflavone supplementation could improve clinical risk factors that predispose to cardiovascular disease in obese postmenopausal women. Design:This was a randomized, double-blind, controlled trial in which 50 healthy obese postmenopausal women were divided into two groups and assigned to isoflavone supplementation (n = 25) or a placebo (n = 25) for 1 year. For the last 6 months, both groups participated in an exercise program (three times per week), at the end of which cardiovascular disease risk factors were compared between groups. Body composition (using dual-energy x-ray absorptiometry), metabolic profile (blood lipids, fasting insulin, fasting glucose, sex hormone-binding globulin, C-reactive protein) were determined at baseline and at 6 and 12 months. Results:We observed a significant effect of exercise and isoflavone supplementation on body weight, total and abdominal fat mass (kilograms and percentage), body mass index, appendicular fat-free mass, fat-free mass/fat mass ratio, and sex hormone-binding globulin, but not with exercise alone. No difference was observed for other biochemical characteristics, although the quantitative insulin sensitivity check index increased equally in both groups. Conversely, although not significant, we observed a tendency for a treatment effect on body mass index (P = 0.07) and on absolute (kilograms) (P = 0.07) and percentage of (P = 0.053) abdominal fat mass, whereas no effect of treatment was found for other variables using the Mann-Whitney test. Conclusions:Compared to an aerobic exercise program alone, 70 mg/day of isoflavones combined with exercise may promote significant improvements in body composition parameters that are known to influence cardiovascular disease risk in postmenopausal women.

Association between obesity and a polymorphism in the beta(1)-adrenoceptor gene (Gly389Arg ADRB1) in Caucasian women.

Introduction: Genetic variants affecting adrenoceptors have been suggested to influence body fatness. A putative gain-of-function polymorphism in the β1-adrenoceptor was recently discovered (Gly389Arg ADRB1). We examined the association between Gly389Arg ADRB1 and obesity status in a large cohort of well-characterized individuals.Methods: First, a large cohort of 931 Caucasian women (55.0±12.2 y) were genotyped for Gly389Arg ADRBβ1 and we examined the association of the Arg allele with body weight and BMI (Gly/Gly, n=54; Gly/Arg, n=360; Arg/Arg, n=517). To further examine phenotypes regulating energy balance and body fatness, we examined the contribution of the Arg allele to body composition (DEXA), fat distribution (CT scan), resting energy expenditure, energy and macronutrient intake, maximal oxygen capacity, and physical activity in a subsample of 214 women from the main cohort that had been carefully characterized (Gly/Gly, n=19; Gly/Arg, n=82; Arg/Arg, n=113).Results: In the entire cohort (n=931), allele frequencies were 0.25 and 0.75 for the Gly and Arg alleles, respectively. In this cohort, we found that each Arg allele was associated with greater body weight of 2.91 kg (P=0.01) and BMI of 0.86 kg/m2 (P=0.05). Accordingly, in the subsample of women, each Arg allele was associated with greater fat mass (3.71 kg; P=0.008). Other phenotypes were not significantly associated with the presence of the Arg allele.Conclusions: This is the first study to investigate the relationship between the Gly389Arg ADRB1 variant and obesity. We found that the Arg allele is associated with greater body weight and BMI in Caucasian women due to a greater fat mass.

The association between vigorous physical activities and fat deposition in male adolescents.

PURPOSE The aim of this study was to investigate the association between participation in vigorous physical activities (VPA) and indicators of adiposity and fat distribution in male adolescents. METHODS Subjects were classified on the basis of the number of reported 15-min periods over 3 d during which VPA were performed. RESULTS Body weight, fat mass, body mass index, sum of six subcutaneous skinfolds, trunk and extremity skinfolds, and trunk to extremity skinfolds ratio (T/E ratio) were all significantly and inversely related to a higher VPA participation. Moreover, T/E ratio was significantly lower in the subgroup reporting a mean of 7.8 15-min periods of activity for 3 d (equivalent to a mean of 39 min x d(-1)) compared with subjects reporting no participation. This decrease in T/E ratio was more pronounced in subjects reporting a mean of 13.6 15-min periods of VPA for 3 d. CONCLUSION These observations reinforce the idea that excess abdominal fat accumulation can be prevented by regular participation in vigorous physical activities.

Age-related differences in metabolic adaptations following resistance training in women

The purpose of this study was to determine whether aging alters changes in resting metabolic rate, body composition and insulin sensitivity in response to resistance training (RT) in women. The impact of a 6-month controlled RT program on fat-free mass (FFM), resting energy expenditure (REE), and glucose disposal was examined in 19 younger (27.8+/-3.5 yr; range 18-35) and 12 older (66.6+/-4.9 yr, range 55-70) non-obese caucasian women. For younger women, the RT program increased body weight (59.1+/-6.2 to 60.8+/-6.1 kg, p<0.05) due to an increase in FFM (39.2+/-3.7-40.4+/-3.2 kg, p<0.05). REE increased from 1379+/-114 to 1451+/-140 kcal day(-1), p<0.0001), and glucose disposal (from 364.1+/-91.1 to 402.1+/-87.8 mg min(-1), p<0.05). Neither fat mass nor VO2max changed significantly. On the other hand, older women lost fat mass (24.0+/-4.6-23.2+/-5.4 kg, p<0.05) and tended to gain FFM (from 37.3+/-4.0-38.0+/-4.3 kg, +1.9%; p=0.057), whereas no change occurred in body weight, REE, VO(2)max or glucose disposal. Thus, younger women showed greater metabolic changes in body composition, REE and insulin sensitivity in response to RT than older women. These results suggest an age-related alteration in metabolic changes in response to a 6-month RT program in previously untrained women.

Gender difference in the effect of body composition on energy metabolism

OBJECTIVE: The aim of this study was to investigate the relationship between energy expenditure (EE) and fat mass (FM) by using a cross-sectional approach to study the linear relationship between body composition variables and EE phenotypes as well as an intervention design to investigate the effect of body weight loss on energy metabolism in both genders.METHODS: The correlations and linear relationships between body weight, FM, fat-free mass (FFM) and abdominal fat vs 24 h EE (EE 24) and sleeping metabolic rate (SMR) were compared between 65 men and 35 women, and before and after weight loss in 10 men and 10 women.RESULTS: Our results showed that for a given FM, men displayed a higher EE than women, independently of FFM. Furthermore, regression analysis revealed that after body weight loss, men displayed a lower SMR for a given FM or FM adjusted for FFM compared to before the treatment, but this was not so in women. However, when FM was adjusted for abdominal fat deposition, the difference between the conditions was no longer observed.CONCLUSIONS: FM has a significant impact on EE only in men. We suggest that abdominal adipose tissue may exert a potent regulatory effect on energy metabolism which would be more detectable in men who generally store more fat in this compartment than women.

Six months of isoflavone supplement increases fat-free mass in obese-sarcopenic postmenopausal women: a randomized double-blind controlled trial.

Objective:The aim of this study was to verify if six months of isoflavone supplementation could increase fat-free mass (FFM) and muscle mass index (MMI=appendicular FFM/height2) in obese–sarcopenic postmenopausal women.Design:Double-blind randomized study.Subject:Eighteen sarcopenic–obese women completed the study (12 on isoflavones and six on placebo). Body composition was measured by dual-energy X-ray absorptiometry. Subjects ingested 70 mg of isoflavones per day (44 mg of diadzein, 16 mg glycitein and 10 mg genestein) or a placebo for 24 weeks.Results:The isoflavone group increased significantly appendicular (P=0.034), leg (P=0.016) FFM and MMI (P=0.037), but not the placebo group.Conclusion:Six months of isoflavone supplementation increased FFM and MMI in obese–sarcopenic postmenopausal women.